<?xml version="1.0" encoding="UTF-8"?><rss version="2.0"
	xmlns:content="http://purl.org/rss/1.0/modules/content/"
	xmlns:wfw="http://wellformedweb.org/CommentAPI/"
	xmlns:dc="http://purl.org/dc/elements/1.1/"
	xmlns:atom="http://www.w3.org/2005/Atom"
	xmlns:sy="http://purl.org/rss/1.0/modules/syndication/"
	xmlns:slash="http://purl.org/rss/1.0/modules/slash/"
	>

<channel>
	<title>Emerging cardiovascular therapies &#8211; BIOENGINEER.ORG</title>
	<atom:link href="https://bioengineer.org/tag/emerging-cardiovascular-therapies/feed/" rel="self" type="application/rss+xml" />
	<link>https://bioengineer.org</link>
	<description>Bioengineering</description>
	<lastBuildDate>Wed, 24 Sep 2025 13:41:17 +0000</lastBuildDate>
	<language>en-US</language>
	<sy:updatePeriod>
	hourly	</sy:updatePeriod>
	<sy:updateFrequency>
	1	</sy:updateFrequency>
	<generator>https://wordpress.org/?v=7.0</generator>

<image>
	<url>https://bioengineer.org/wp-content/uploads/2019/09/cropped-bioengineering-32x32.png</url>
	<title>Emerging cardiovascular therapies &#8211; BIOENGINEER.ORG</title>
	<link>https://bioengineer.org</link>
	<width>32</width>
	<height>32</height>
</image> 
<site xmlns="com-wordpress:feed-additions:1">72741379</site>	<item>
		<title>Predictive Lab Tests for Cardiac Events Remain Rare but Are on the Rise</title>
		<link>https://bioengineer.org/predictive-lab-tests-for-cardiac-events-remain-rare-but-are-on-the-rise/</link>
		
		<dc:creator><![CDATA[Bioengineer]]></dc:creator>
		<pubDate>Wed, 24 Sep 2025 13:41:15 +0000</pubDate>
				<category><![CDATA[Health]]></category>
		<category><![CDATA[Cardiovascular risk disparities]]></category>
		<category><![CDATA[Emerging cardiovascular therapies]]></category>
		<category><![CDATA[Genetic heart disease markers]]></category>
		<category><![CDATA[Lipoprotein(a) testing]]></category>
		<category><![CDATA[U.S. vs European healthcare practices]]></category>
		<guid isPermaLink="false">https://bioengineer.org/predictive-lab-tests-for-cardiac-events-remain-rare-but-are-on-the-rise/</guid>

					<description><![CDATA[In a groundbreaking new study published in the Journal of the American College of Cardiology: Advances, researchers at the University of California San Diego School of Medicine have unveiled compelling evidence that testing for lipoprotein(a), commonly abbreviated as Lp(a), remains woefully uncommon across the United States. Despite the recognized importance of Lp(a) as a genetic [&#8230;]]]></description>
		
		
		
		<post-id xmlns="com-wordpress:feed-additions:1">271747</post-id>	</item>
	</channel>
</rss>
